Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Macquarie has increased its annual recurring revenue (ARR) forecasts for Zhipu AI to $2 billion for 2026 and $4.5 billion for 2027, pointing to the company’s competitive lead in code generation through its GLM 5-2 model. Zhipu surpassed $1 billion in ARR in July, ahead of its full-year goal. Both Zhipu and rival Minimax completed post-lock-up equit…
Zealand Pharma shares moved lower after Jefferies downgraded the stock from Buy to Hold and cut its price target to DKK 320 from DKK 505, citing a lack of near-term value-crystallising events in the second half of 2026 and lowering the probability of success for survodutide to 40% from 60%. The downgrade compounded earlier analyst concerns over sur…
Befesa shares rose after Morgan Stanley reafirmed an Overweight rating and set a EUR 37.00 target, highlighting compressed valuation and an estimated 11% free cash flow yield. Investors also appear to be positioning ahead of Q2 2026 results due July 29, supported by a solid Q1 performance and reiterated full-year adjusted EBITDA guidance.
Barclays cut its recommendation on Unicaja Banco to underweight from equal weight, arguing that a recent re-rating has made the Spanish lender's stock appear expensive on a price-to-earnings versus EPS growth basis. The broker raised its price target to €3.10 from €3, while maintaining a generally stable operational outlook and modestly improving e…
O-I Glass fell in pre-market trading after BofA Securities cut its rating from Buy to Underperform and lowered its price target to $11, citing growing doubts that management can reach its roughly $1.4 billion EBITDA target for 2027. The downgrade followed other negative analyst moves and came as a broader market decline driven by renewed geopolitic…
Morgan Stanley projects Apple will raise iPhone prices by roughly $200 in September, a move the bank estimates could add about 2-4% to fiscal third-quarter 2026 EPS and roughly 1% to fiscal 2027 EPS. The firm maintains an Overweight rating, citing limited consumer sensitivity to hardware price increases, stable build plans from supply-chain checks,…
Spero Therapeutics said it has closed a $105 million licensing financing with affiliates of Healthcare Royalty, a KKR business, in exchange for rights to a portion of future payments tied to sales of Utebzi (tebipenem pivoxil). The deal, which closed alongside an exclusive license agreement with Innovent Biologics for the SP001 asset, prompted roug…
Zoetis has been punished after a string of negative headlines and litigation filings tied to companion-animal product adoption. The share price now trades near its 52-week low despite $2.1B in free cash flow, an EV/EBITDA of ~9.5x, and a dividend yield near 2.8%. For risk-tolerant, event-driven traders, this is a pragmatic long with a tight stop an…
FuelCell Energy shares jumped about 9% in pre-market trading after UBS upgraded the stock from Neutral to Buy and raised its target to $27 from $22. The upgrade provides a company-specific catalyst as the stock attempts to stabilize near the $21 per-share level established by a recent $225 million secondary offering that had driven a sharp decline …
Apple Inc. shares fell in pre-market trade after KeyBanc cut its rating to Underweight, adding to downward pressure from a recent federal lawsuit against OpenAI and persistent industry headwinds including an 11% drop in global smartphone shipments in Q2 2026. The combination of an elevated valuation, sector weakness and supply-driven cost pressures…
CleanSpark announced a 20-year infrastructure lease at its Sandersville, Georgia data center campus with an unnamed global technology tenant. The initial term is expected to generate roughly $6.6 billion in contracted revenue, with two five-year extension options that could raise the contract value to $11.6 billion. The deal is structured as a trip…
Federal Reserve Chair Kevin Warsh will testify before Congress on July 14 in his first appearance since assuming leadership of the U.S. central bank. While Warsh has outlined several positions during public remarks and his Senate confirmation, key questions remain on how he views labor market trajectories, his stance on the 2% inflation goal, the r…
Federal Reserve Chair Kevin Warsh will testify before Congress over two days as he lays out his initial thinking on monetary policy and the economy. His early actions - including task force appointments and staffing choices - have been read by some observers as creating distance from President Donald Trump, even as questions remain about whether Wa…
Supreme Court Justices Amy Coney Barrett and Elena Kagan will appear before House and Senate appropriations subcommittees to explain the judiciary's funding request for the next fiscal year. The court is seeking roughly $230 million - about a 10% increase - with more than $14 million earmarked to expand protective activities for justices' residence…
PepsiCo’s effort to revive growth in its core North American business has hit a plateau as Americans alter snacking and beverage choices. Sales in the company’s North America food unit fell 2% in the second quarter ended June 13 and volumes were flat, even after price reductions of up to 15% on major snack brands. Broader trends - including rapid G…
Tower Semiconductor said it will invest $3 billion to expand manufacturing in Japan, with the Japanese government providing $1 billion in grants. The project centers on silicon photonics and silicon-germanium (SiGe) technologies to serve rising AI and data center needs. The plan unfolds in two concurrent phases, with initial 300mm silicon photonics…
Todd Blanche heads into a high-stakes Senate confirmation hearing as acting attorney general with a slate of controversies at his back: representation of the president, a suspended $1.8 billion settlement fund criticized as a potential tool for political weaponization, and pressure from Democrats, former prosecutors and survivors of Jeffrey Epstein…
Bank of England Governor Andrew Bailey told lawmakers that while the UK banking system remains resilient, the breakdown in talks and renewed attacks between the United States and Iran have elevated financial stability risks. Bailey said he had assessed the conflict risk at the lower end of the BoE’s scenario range when he voted last month in favor …
Federal subpoenas have been issued to New York Times reporters ordering them to appear before a Manhattan federal grand jury after articles flagged security shortcomings in the new Qatari-donated presidential plane. The paper says it will contest the orders; prosecutors say they are pursuing the source of classified disclosures. The legal fight wil…
UiPath is trading at a $6.1B market cap after proving it can grow revenue and hit GAAP profitability. The market is skeptical about the company's ability to monetize agentic AI orchestration. That skepticism creates a clear trade: a long position executing into near-term volatility with a long-term horizon to allow adoption of agentic automation to…
Summary: Circle Internet Group stock fell 0.7% in pre-market trading after Mizuho lowered its rating to Underperform, citing competitive pressures that could materially compress the firm's revenue model. The drop pared part of a prior session rally that followed final approval from the Office of the Comptroller of the Currency for a national digita…
Bank of America’s July Global Fund Manager Survey shows investor sentiment shifting strongly positive, with cash allocations dropping to 3.6% of assets and bullish indicators triggering contrarian sell signals. Panelists raised overweight positions in U.S. equities and signaled rising confidence in a 'no landing' economic outcome and a 'boom' scena…
The sudden passing of U.S. Senator Lindsey Graham, a close interlocutor between Kyiv and President Donald Trump, leaves uncertainty over whether the recent U.S. tilt toward supporting Ukraine will continue. Graham had been central to efforts to advance a sanctions bill targeting Russian energy purchasers and to secure expanded military assistance f…
Spero Therapeutics announced a $105 million non-recourse, non-dilutive royalty financing deal backed by future milestone and royalty payments from Utebzi sales. The funding supports the Phase 2 clinical development of SP001, an immunology-focused monoclonal antibody acquired from Innovent Biologics. The transaction extends Spero's cash runway into …
NextCure, Inc. and privately-held Avere Therapeutics announced a definitive all-stock merger agreement to combine their efforts in developing AVR-001, a once-weekly oral IL-23 receptor antagonist targeting inflammatory diseases such as psoriasis and ulcerative colitis. A concurrent $320 million private investment led by global healthcare investors …
